Diflorasone Diacetate

Generic Name: diflorasone diacetate

Over-the-Counter (OTC)

Brand Names:

Diflorasone Diacetate

DESCRIPTION Diflorasone diacetate cream USP, 0.05% contains the active compound diflorasone diacetate, a synthetic corticosteroid for topical dermatological use. Chemically, diflorasone diacetate is 6α, 9α-difluoro-11β,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17,21 diacetate, with the empirical formula C 26 H 32 F 2 O 7 , a molecular weight of 494.5, and the following structural formula: Each gram of diflorasone diacetate cream USP, 0.05% contains 0.5 mg diflorasone diacetate in a c...

Overview

DESCRIPTION Diflorasone diacetate cream USP, 0.05% contains the active compound diflorasone diacetate, a synthetic corticosteroid for topical dermatological use. Chemically, diflorasone diacetate is 6α, 9α-difluoro-11β,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17,21 diacetate, with the empirical formula C 26 H 32 F 2 O 7 , a molecular weight of 494.5, and the following structural formula: Each gram of diflorasone diacetate cream USP, 0.05% contains 0.5 mg diflorasone diacetate in a c...

Uses

INDICATION AND USAGE Diflorasone diacetate cream USP, 0.05% is a high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Dosage

DOSAGE AND ADMINISTRATION Diflorasone diacetate cream USP, 0.05% should be applied to the affected area twice daily.

Side Effects

ADVERSE REACTIONS The following local adverse reactions have been reported infrequently with other topical corticosteroids, and they may occur more frequently with the use of occlusive dressings, especially with higher potency corticosteroids. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infections, skin atrophy, striae, and miliaria. To report SUSPECTED ADVERSE REACTIONS, contact Sun Pharmaceutical Industries, Inc. at 1-866-923-4914 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Warnings

CONTRAINDICATIONS Diflorasone diacetate cream USP is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Pregnancy

Pregnancy Teratogenic effects Pregnancy Category C Corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. Some corticosteroids have been shown to be teratogenic after dermal application to laboratory animals. Diflorasone diacetate has been shown to be teratogenic (cleft palate) in rats when applied topically at a dose of approximately 0.001 mg/kg/day to the shaven thorax of pregnant animals. This is approximately 0.3 times the human topical dose of diflorasone diacetate cream USP, 0.05%.

Storage

Store at 20 ° to 25 ° C (68 ° to 77 ° F) [see USP Controlled Room Temperature]. Keep tightly closed.

Frequently Asked Questions

What is Diflorasone Diacetate used for?

INDICATION AND USAGE Diflorasone diacetate cream USP, 0.05% is a high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

What are the side effects of Diflorasone Diacetate?

ADVERSE REACTIONS The following local adverse reactions have been reported infrequently with other topical corticosteroids, and they may occur more frequently with the use of occlusive dressings, especially with higher potency corticosteroids. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infections, skin atrophy, striae, and miliaria. To report SUSPECTED ADVERSE REACTIONS, contact Sun Pharmaceutical Industries, Inc. at 1-866-923-4914 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Can I take Diflorasone Diacetate during pregnancy?

Pregnancy Teratogenic effects Pregnancy Category C Corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. Some corticosteroids have been shown to be teratogenic after dermal application to laboratory animals. Diflorasone diacetate has been shown to be teratogenic (cleft palate) in rats when applied topically at a dose of approximately 0.001 mg/kg/day to the shaven thorax of pregnant animals. This is approximately 0.3 times the human topical dose of diflorasone diacetate cream USP, 0.05%.

What are the important warnings for Diflorasone Diacetate?

CONTRAINDICATIONS Diflorasone diacetate cream USP is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Related Medications

Insulin Lispro-aabc

insulin lispro-aabc

Insulin Analog [EPC]

11 DESCRIPTION Insulin lispro-aabc is a rapid-acting human insulin analog used to lower blood glucose. Insulin lispro-aabc is produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of Escherichia coli . Insulin lispro-aabc differs from human insulin in that the amino acid proline at position B28 is replaced by lysine and the lysine in position B29 is replaced by proline.

Teucrium Scorodonia, Veronica Officinalis, Equisetum Hyemale, Fumaria Officinalis, Geranium Robertianum, Nasturtium Aquaticum, Natrum Sulphuricum, Pinus Sylvestris, Gentiana Lutea, Sarsaparilla (smilax Regelii), Scrophularia Nodosa, Myosotis Arvensis, Aranea Diadema, Juglans Regia, Calcarea Phosphorica, Ferrum Iodatum, Lymph Node (suis), Thyroidinum (suis)

teucrium scorodonia, veronica officinalis, equisetum hyemale, fumaria officinalis, geranium robertianum, nasturtium aquaticum, natrum sulphuricum, pinus sylvestris, gentiana lutea, sarsaparilla (smilax regelii), scrophularia nodosa, myosotis arvensis, aranea diadema, juglans regia, calcarea phosphorica, ferrum iodatum, lymph node (suis), thyroidinum (suis)

PURPOSE: Aranea Diadema – Throat Inflammation, Calcarea Phosphorica - Cough, Equisetum Hyemale – Throat Pain, Ferrum Iodatum - Sneezing, Fumaria Officinalis – Throat Pain, Gentiana Lutea - Sneezing, Geranium Robertianum - Cough, Juglans Regia – Throat Inflammation, Lymph Node (Suis) – Throat Inflammation, Myosotis Arvensis - Cough, Nasturtium Aquaticum - Sneezing, Natrum Sulphuricum - Sneezing, Pinus Sylvestris - Cough, Sarsaparilla (Smilax Regelii) – Throat Pain, Scrophularia Nodosa – Throat In

Levopropoxyphene Napsylate Anhydrous

levopropoxyphene napsylate anhydrous

Manufactured by LILLY. Dosage form: SUSPENSION. Route: ORAL. Active ingredients: LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS (EQ 50MG BASE/5ML). Application: NDA012928.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.